Immune checkpoint inhibitors and the risk of atrio-ventricular block - a pharmacovigilance analysis

Authors

Mohan Chandra Vinay Bharadwaj Gudiwada, Advocate Aurora HealthFollow
Ankit Sahni, Advocate Aurora HealthFollow
Riya Mary Sam, Advocate Aurora HealthFollow
Vinuthna Gaddam, Advocate Aurora Health
Jaswanth Jasti, Advocate Aurora Health
Harsha Sai Sreemantula, Advocate Aurora Health

Recommended Citation

Gudiwada MCVB, Sahni A, Sam RM, Gaddam V, Jasti J, Sreemantula HS. Immune Checkpoint Inhibitors and the Risk of Atrio-Ventricular Block - a Pharmacovigilance Analysis. Journal of the American College of Cardiology (JACC). 2023;81:2206. doi:10.1016/S0735-1097(23)02650-5

Affiliations

Advocate Illinois Masonic Medical Center

Type

Abstract